Spectrum Pharma (SPPI) Tops Q3 EPS by 13c, Beats on Revenues

November 2, 2017 4:49 PM EDT

Spectrum Pharma (NASDAQ: SPPI) reported Q3 EPS of ($0.11), $0.13 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $36.4 million versus the consensus estimate of $33.15 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings